Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane.

상세 보기

Citations

WEB OF SCIENCE

1

제목: Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor plus (HR+), HER2-metastatic breast cancer (MBC) not previously treated with a taxane.

저자: Schwartzberg, Lee S.; Bondarenko, Igor; Tolaney, Sara M.; Seidman, Andrew David; O'Shaughnessy, Joyce; Shparyk, Yaroslav V.; Chung, Chi-Feng; Lu, Yen-Shen; Chic, Nuria; Panasci, Lawrence C.; Chae, Yee Soo; Recalde, Sabela; Hotko, Yevhen; Gomez, Patricia; Shaw Wright, Gail Lynn; Anthony Dacosta, Noshir; Vatandoust, Sina; O'Connell, Joseph P.; Wei, Thomas; Rugo, Hope S.